Global Psoriatic Arthritis (PsA) Treatment Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Psoriatic Arthritis (PsA) Treatment Industry Forecast” looks at past sales and reviews total world Psoriatic Arthritis (PsA) Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Psoriatic Arthritis (PsA) Treatment sales for 2023 through 2029. With Psoriatic Arthritis (PsA) Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Psoriatic Arthritis (PsA) Treatment industry.
This Insight Report provides a comprehensive analysis of the global Psoriatic Arthritis (PsA) Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Psoriatic Arthritis (PsA) Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Psoriatic Arthritis (PsA) Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Psoriatic Arthritis (PsA) Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Psoriatic Arthritis (PsA) Treatment.
The global Psoriatic Arthritis (PsA) Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Psoriatic Arthritis (PsA) Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Psoriatic Arthritis (PsA) Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Psoriatic Arthritis (PsA) Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Psoriatic Arthritis (PsA) Treatment players cover Pfizer, Johnson & Johnson, AbbVie, Novartis, UCB, Roche, Bristol-Myers Squibb, Eli Lilly and Amgen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Psoriatic Arthritis (PsA) Treatment market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Psoriatic Arthritis (PsA) Treatment Industry Forecast” looks at past sales and reviews total world Psoriatic Arthritis (PsA) Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Psoriatic Arthritis (PsA) Treatment sales for 2023 through 2029. With Psoriatic Arthritis (PsA) Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Psoriatic Arthritis (PsA) Treatment industry.
This Insight Report provides a comprehensive analysis of the global Psoriatic Arthritis (PsA) Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Psoriatic Arthritis (PsA) Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Psoriatic Arthritis (PsA) Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Psoriatic Arthritis (PsA) Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Psoriatic Arthritis (PsA) Treatment.
The global Psoriatic Arthritis (PsA) Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Psoriatic Arthritis (PsA) Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Psoriatic Arthritis (PsA) Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Psoriatic Arthritis (PsA) Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Psoriatic Arthritis (PsA) Treatment players cover Pfizer, Johnson & Johnson, AbbVie, Novartis, UCB, Roche, Bristol-Myers Squibb, Eli Lilly and Amgen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Psoriatic Arthritis (PsA) Treatment market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Nonsteriodal Anti-inflammatory Drugs
- Disease Modifying Antirheumatic Drugs
- Biologics
- Hospitals
- Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Johnson & Johnson
- AbbVie
- Novartis
- UCB
- Roche
- Bristol-Myers Squibb
- Eli Lilly
- Amgen
- AstraZeneca
- Celgene
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Psoriatic Arthritis (PsA) Treatment Market Size 2018-2029
2.1.2 Psoriatic Arthritis (PsA) Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Psoriatic Arthritis (PsA) Treatment Segment by Type
2.2.1 Nonsteriodal Anti-inflammatory Drugs
2.2.2 Disease Modifying Antirheumatic Drugs
2.2.3 Biologics
2.3 Psoriatic Arthritis (PsA) Treatment Market Size by Type
2.3.1 Psoriatic Arthritis (PsA) Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2018-2023)
2.4 Psoriatic Arthritis (PsA) Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Psoriatic Arthritis (PsA) Treatment Market Size by Application
2.5.1 Psoriatic Arthritis (PsA) Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2018-2023)
3 PSORIATIC ARTHRITIS (PSA) TREATMENT MARKET SIZE BY PLAYER
3.1 Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Players
3.1.1 Global Psoriatic Arthritis (PsA) Treatment Revenue by Players (2018-2023)
3.1.2 Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Psoriatic Arthritis (PsA) Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PSORIATIC ARTHRITIS (PSA) TREATMENT BY REGIONS
4.1 Psoriatic Arthritis (PsA) Treatment Market Size by Regions (2018-2023)
4.2 Americas Psoriatic Arthritis (PsA) Treatment Market Size Growth (2018-2023)
4.3 APAC Psoriatic Arthritis (PsA) Treatment Market Size Growth (2018-2023)
4.4 Europe Psoriatic Arthritis (PsA) Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Psoriatic Arthritis (PsA) Treatment Market Size by Country (2018-2023)
5.2 Americas Psoriatic Arthritis (PsA) Treatment Market Size by Type (2018-2023)
5.3 Americas Psoriatic Arthritis (PsA) Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Psoriatic Arthritis (PsA) Treatment Market Size by Region (2018-2023)
6.2 APAC Psoriatic Arthritis (PsA) Treatment Market Size by Type (2018-2023)
6.3 APAC Psoriatic Arthritis (PsA) Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Psoriatic Arthritis (PsA) Treatment by Country (2018-2023)
7.2 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type (2018-2023)
7.3 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Psoriatic Arthritis (PsA) Treatment by Region (2018-2023)
8.2 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PSORIATIC ARTHRITIS (PSA) TREATMENT MARKET FORECAST
10.1 Global Psoriatic Arthritis (PsA) Treatment Forecast by Regions (2024-2029)
10.1.1 Global Psoriatic Arthritis (PsA) Treatment Forecast by Regions (2024-2029)
10.1.2 Americas Psoriatic Arthritis (PsA) Treatment Forecast
10.1.3 APAC Psoriatic Arthritis (PsA) Treatment Forecast
10.1.4 Europe Psoriatic Arthritis (PsA) Treatment Forecast
10.1.5 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Forecast
10.2 Americas Psoriatic Arthritis (PsA) Treatment Forecast by Country (2024-2029)
10.2.1 United States Psoriatic Arthritis (PsA) Treatment Market Forecast
10.2.2 Canada Psoriatic Arthritis (PsA) Treatment Market Forecast
10.2.3 Mexico Psoriatic Arthritis (PsA) Treatment Market Forecast
10.2.4 Brazil Psoriatic Arthritis (PsA) Treatment Market Forecast
10.3 APAC Psoriatic Arthritis (PsA) Treatment Forecast by Region (2024-2029)
10.3.1 China Psoriatic Arthritis (PsA) Treatment Market Forecast
10.3.2 Japan Psoriatic Arthritis (PsA) Treatment Market Forecast
10.3.3 Korea Psoriatic Arthritis (PsA) Treatment Market Forecast
10.3.4 Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Forecast
10.3.5 India Psoriatic Arthritis (PsA) Treatment Market Forecast
10.3.6 Australia Psoriatic Arthritis (PsA) Treatment Market Forecast
10.4 Europe Psoriatic Arthritis (PsA) Treatment Forecast by Country (2024-2029)
10.4.1 Germany Psoriatic Arthritis (PsA) Treatment Market Forecast
10.4.2 France Psoriatic Arthritis (PsA) Treatment Market Forecast
10.4.3 UK Psoriatic Arthritis (PsA) Treatment Market Forecast
10.4.4 Italy Psoriatic Arthritis (PsA) Treatment Market Forecast
10.4.5 Russia Psoriatic Arthritis (PsA) Treatment Market Forecast
10.5 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Forecast by Region (2024-2029)
10.5.1 Egypt Psoriatic Arthritis (PsA) Treatment Market Forecast
10.5.2 South Africa Psoriatic Arthritis (PsA) Treatment Market Forecast
10.5.3 Israel Psoriatic Arthritis (PsA) Treatment Market Forecast
10.5.4 Turkey Psoriatic Arthritis (PsA) Treatment Market Forecast
10.5.5 GCC Countries Psoriatic Arthritis (PsA) Treatment Market Forecast
10.6 Global Psoriatic Arthritis (PsA) Treatment Forecast by Type (2024-2029)
10.7 Global Psoriatic Arthritis (PsA) Treatment Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Psoriatic Arthritis (PsA) Treatment Product Offered
11.1.3 Pfizer Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Product Offered
11.2.3 Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 AbbVie
11.3.1 AbbVie Company Information
11.3.2 AbbVie Psoriatic Arthritis (PsA) Treatment Product Offered
11.3.3 AbbVie Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 AbbVie Main Business Overview
11.3.5 AbbVie Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Psoriatic Arthritis (PsA) Treatment Product Offered
11.4.3 Novartis Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 UCB
11.5.1 UCB Company Information
11.5.2 UCB Psoriatic Arthritis (PsA) Treatment Product Offered
11.5.3 UCB Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 UCB Main Business Overview
11.5.5 UCB Latest Developments
11.6 Roche
11.6.1 Roche Company Information
11.6.2 Roche Psoriatic Arthritis (PsA) Treatment Product Offered
11.6.3 Roche Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Roche Main Business Overview
11.6.5 Roche Latest Developments
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Information
11.7.2 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Product Offered
11.7.3 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Bristol-Myers Squibb Main Business Overview
11.7.5 Bristol-Myers Squibb Latest Developments
11.8 Eli Lilly
11.8.1 Eli Lilly Company Information
11.8.2 Eli Lilly Psoriatic Arthritis (PsA) Treatment Product Offered
11.8.3 Eli Lilly Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Eli Lilly Main Business Overview
11.8.5 Eli Lilly Latest Developments
11.9 Amgen
11.9.1 Amgen Company Information
11.9.2 Amgen Psoriatic Arthritis (PsA) Treatment Product Offered
11.9.3 Amgen Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Amgen Main Business Overview
11.9.5 Amgen Latest Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Company Information
11.10.2 AstraZeneca Psoriatic Arthritis (PsA) Treatment Product Offered
11.10.3 AstraZeneca Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 AstraZeneca Main Business Overview
11.10.5 AstraZeneca Latest Developments
11.11 Celgene
11.11.1 Celgene Company Information
11.11.2 Celgene Psoriatic Arthritis (PsA) Treatment Product Offered
11.11.3 Celgene Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Celgene Main Business Overview
11.11.5 Celgene Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Psoriatic Arthritis (PsA) Treatment Market Size 2018-2029
2.1.2 Psoriatic Arthritis (PsA) Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Psoriatic Arthritis (PsA) Treatment Segment by Type
2.2.1 Nonsteriodal Anti-inflammatory Drugs
2.2.2 Disease Modifying Antirheumatic Drugs
2.2.3 Biologics
2.3 Psoriatic Arthritis (PsA) Treatment Market Size by Type
2.3.1 Psoriatic Arthritis (PsA) Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2018-2023)
2.4 Psoriatic Arthritis (PsA) Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Psoriatic Arthritis (PsA) Treatment Market Size by Application
2.5.1 Psoriatic Arthritis (PsA) Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2018-2023)
3 PSORIATIC ARTHRITIS (PSA) TREATMENT MARKET SIZE BY PLAYER
3.1 Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Players
3.1.1 Global Psoriatic Arthritis (PsA) Treatment Revenue by Players (2018-2023)
3.1.2 Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Psoriatic Arthritis (PsA) Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PSORIATIC ARTHRITIS (PSA) TREATMENT BY REGIONS
4.1 Psoriatic Arthritis (PsA) Treatment Market Size by Regions (2018-2023)
4.2 Americas Psoriatic Arthritis (PsA) Treatment Market Size Growth (2018-2023)
4.3 APAC Psoriatic Arthritis (PsA) Treatment Market Size Growth (2018-2023)
4.4 Europe Psoriatic Arthritis (PsA) Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Psoriatic Arthritis (PsA) Treatment Market Size by Country (2018-2023)
5.2 Americas Psoriatic Arthritis (PsA) Treatment Market Size by Type (2018-2023)
5.3 Americas Psoriatic Arthritis (PsA) Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Psoriatic Arthritis (PsA) Treatment Market Size by Region (2018-2023)
6.2 APAC Psoriatic Arthritis (PsA) Treatment Market Size by Type (2018-2023)
6.3 APAC Psoriatic Arthritis (PsA) Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Psoriatic Arthritis (PsA) Treatment by Country (2018-2023)
7.2 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type (2018-2023)
7.3 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Psoriatic Arthritis (PsA) Treatment by Region (2018-2023)
8.2 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PSORIATIC ARTHRITIS (PSA) TREATMENT MARKET FORECAST
10.1 Global Psoriatic Arthritis (PsA) Treatment Forecast by Regions (2024-2029)
10.1.1 Global Psoriatic Arthritis (PsA) Treatment Forecast by Regions (2024-2029)
10.1.2 Americas Psoriatic Arthritis (PsA) Treatment Forecast
10.1.3 APAC Psoriatic Arthritis (PsA) Treatment Forecast
10.1.4 Europe Psoriatic Arthritis (PsA) Treatment Forecast
10.1.5 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Forecast
10.2 Americas Psoriatic Arthritis (PsA) Treatment Forecast by Country (2024-2029)
10.2.1 United States Psoriatic Arthritis (PsA) Treatment Market Forecast
10.2.2 Canada Psoriatic Arthritis (PsA) Treatment Market Forecast
10.2.3 Mexico Psoriatic Arthritis (PsA) Treatment Market Forecast
10.2.4 Brazil Psoriatic Arthritis (PsA) Treatment Market Forecast
10.3 APAC Psoriatic Arthritis (PsA) Treatment Forecast by Region (2024-2029)
10.3.1 China Psoriatic Arthritis (PsA) Treatment Market Forecast
10.3.2 Japan Psoriatic Arthritis (PsA) Treatment Market Forecast
10.3.3 Korea Psoriatic Arthritis (PsA) Treatment Market Forecast
10.3.4 Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Forecast
10.3.5 India Psoriatic Arthritis (PsA) Treatment Market Forecast
10.3.6 Australia Psoriatic Arthritis (PsA) Treatment Market Forecast
10.4 Europe Psoriatic Arthritis (PsA) Treatment Forecast by Country (2024-2029)
10.4.1 Germany Psoriatic Arthritis (PsA) Treatment Market Forecast
10.4.2 France Psoriatic Arthritis (PsA) Treatment Market Forecast
10.4.3 UK Psoriatic Arthritis (PsA) Treatment Market Forecast
10.4.4 Italy Psoriatic Arthritis (PsA) Treatment Market Forecast
10.4.5 Russia Psoriatic Arthritis (PsA) Treatment Market Forecast
10.5 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Forecast by Region (2024-2029)
10.5.1 Egypt Psoriatic Arthritis (PsA) Treatment Market Forecast
10.5.2 South Africa Psoriatic Arthritis (PsA) Treatment Market Forecast
10.5.3 Israel Psoriatic Arthritis (PsA) Treatment Market Forecast
10.5.4 Turkey Psoriatic Arthritis (PsA) Treatment Market Forecast
10.5.5 GCC Countries Psoriatic Arthritis (PsA) Treatment Market Forecast
10.6 Global Psoriatic Arthritis (PsA) Treatment Forecast by Type (2024-2029)
10.7 Global Psoriatic Arthritis (PsA) Treatment Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Psoriatic Arthritis (PsA) Treatment Product Offered
11.1.3 Pfizer Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Product Offered
11.2.3 Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 AbbVie
11.3.1 AbbVie Company Information
11.3.2 AbbVie Psoriatic Arthritis (PsA) Treatment Product Offered
11.3.3 AbbVie Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 AbbVie Main Business Overview
11.3.5 AbbVie Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Psoriatic Arthritis (PsA) Treatment Product Offered
11.4.3 Novartis Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 UCB
11.5.1 UCB Company Information
11.5.2 UCB Psoriatic Arthritis (PsA) Treatment Product Offered
11.5.3 UCB Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 UCB Main Business Overview
11.5.5 UCB Latest Developments
11.6 Roche
11.6.1 Roche Company Information
11.6.2 Roche Psoriatic Arthritis (PsA) Treatment Product Offered
11.6.3 Roche Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Roche Main Business Overview
11.6.5 Roche Latest Developments
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Information
11.7.2 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Product Offered
11.7.3 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Bristol-Myers Squibb Main Business Overview
11.7.5 Bristol-Myers Squibb Latest Developments
11.8 Eli Lilly
11.8.1 Eli Lilly Company Information
11.8.2 Eli Lilly Psoriatic Arthritis (PsA) Treatment Product Offered
11.8.3 Eli Lilly Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Eli Lilly Main Business Overview
11.8.5 Eli Lilly Latest Developments
11.9 Amgen
11.9.1 Amgen Company Information
11.9.2 Amgen Psoriatic Arthritis (PsA) Treatment Product Offered
11.9.3 Amgen Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Amgen Main Business Overview
11.9.5 Amgen Latest Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Company Information
11.10.2 AstraZeneca Psoriatic Arthritis (PsA) Treatment Product Offered
11.10.3 AstraZeneca Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 AstraZeneca Main Business Overview
11.10.5 AstraZeneca Latest Developments
11.11 Celgene
11.11.1 Celgene Company Information
11.11.2 Celgene Psoriatic Arthritis (PsA) Treatment Product Offered
11.11.3 Celgene Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Celgene Main Business Overview
11.11.5 Celgene Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Psoriatic Arthritis (PsA) Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Nonsteriodal Anti-inflammatory Drugs
Table 3. Major Players of Disease Modifying Antirheumatic Drugs
Table 4. Major Players of Biologics
Table 5. Psoriatic Arthritis (PsA) Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Psoriatic Arthritis (PsA) Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2018-2023)
Table 8. Psoriatic Arthritis (PsA) Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Psoriatic Arthritis (PsA) Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2018-2023)
Table 11. Global Psoriatic Arthritis (PsA) Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Player (2018-2023)
Table 13. Psoriatic Arthritis (PsA) Treatment Key Players Head office and Products Offered
Table 14. Psoriatic Arthritis (PsA) Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Psoriatic Arthritis (PsA) Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Regions (2018-2023)
Table 19. Global Psoriatic Arthritis (PsA) Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Psoriatic Arthritis (PsA) Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Country (2018-2023)
Table 23. Americas Psoriatic Arthritis (PsA) Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2018-2023)
Table 25. Americas Psoriatic Arthritis (PsA) Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2018-2023)
Table 27. APAC Psoriatic Arthritis (PsA) Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Region (2018-2023)
Table 29. APAC Psoriatic Arthritis (PsA) Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2018-2023)
Table 31. APAC Psoriatic Arthritis (PsA) Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2018-2023)
Table 33. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Country (2018-2023)
Table 35. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2018-2023)
Table 37. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Psoriatic Arthritis (PsA) Treatment
Table 46. Key Market Challenges & Risks of Psoriatic Arthritis (PsA) Treatment
Table 47. Key Industry Trends of Psoriatic Arthritis (PsA) Treatment
Table 48. Global Psoriatic Arthritis (PsA) Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Psoriatic Arthritis (PsA) Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Psoriatic Arthritis (PsA) Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Pfizer Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 53. Pfizer Psoriatic Arthritis (PsA) Treatment Product Offered
Table 54. Pfizer Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Pfizer Main Business
Table 56. Pfizer Latest Developments
Table 57. Johnson & Johnson Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 58. Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Product Offered
Table 59. Johnson & Johnson Main Business
Table 60. Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Johnson & Johnson Latest Developments
Table 62. AbbVie Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 63. AbbVie Psoriatic Arthritis (PsA) Treatment Product Offered
Table 64. AbbVie Main Business
Table 65. AbbVie Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. AbbVie Latest Developments
Table 67. Novartis Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 68. Novartis Psoriatic Arthritis (PsA) Treatment Product Offered
Table 69. Novartis Main Business
Table 70. Novartis Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Novartis Latest Developments
Table 72. UCB Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 73. UCB Psoriatic Arthritis (PsA) Treatment Product Offered
Table 74. UCB Main Business
Table 75. UCB Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. UCB Latest Developments
Table 77. Roche Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 78. Roche Psoriatic Arthritis (PsA) Treatment Product Offered
Table 79. Roche Main Business
Table 80. Roche Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Roche Latest Developments
Table 82. Bristol-Myers Squibb Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 83. Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Product Offered
Table 84. Bristol-Myers Squibb Main Business
Table 85. Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Bristol-Myers Squibb Latest Developments
Table 87. Eli Lilly Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 88. Eli Lilly Psoriatic Arthritis (PsA) Treatment Product Offered
Table 89. Eli Lilly Main Business
Table 90. Eli Lilly Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Eli Lilly Latest Developments
Table 92. Amgen Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 93. Amgen Psoriatic Arthritis (PsA) Treatment Product Offered
Table 94. Amgen Main Business
Table 95. Amgen Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Amgen Latest Developments
Table 97. AstraZeneca Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 98. AstraZeneca Psoriatic Arthritis (PsA) Treatment Product Offered
Table 99. AstraZeneca Main Business
Table 100. AstraZeneca Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. AstraZeneca Latest Developments
Table 102. Celgene Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 103. Celgene Psoriatic Arthritis (PsA) Treatment Product Offered
Table 104. Celgene Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Celgene Main Business
Table 106. Celgene Latest Developments
Table 1. Psoriatic Arthritis (PsA) Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Nonsteriodal Anti-inflammatory Drugs
Table 3. Major Players of Disease Modifying Antirheumatic Drugs
Table 4. Major Players of Biologics
Table 5. Psoriatic Arthritis (PsA) Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Psoriatic Arthritis (PsA) Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2018-2023)
Table 8. Psoriatic Arthritis (PsA) Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Psoriatic Arthritis (PsA) Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2018-2023)
Table 11. Global Psoriatic Arthritis (PsA) Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Player (2018-2023)
Table 13. Psoriatic Arthritis (PsA) Treatment Key Players Head office and Products Offered
Table 14. Psoriatic Arthritis (PsA) Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Psoriatic Arthritis (PsA) Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Regions (2018-2023)
Table 19. Global Psoriatic Arthritis (PsA) Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Psoriatic Arthritis (PsA) Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Country (2018-2023)
Table 23. Americas Psoriatic Arthritis (PsA) Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2018-2023)
Table 25. Americas Psoriatic Arthritis (PsA) Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2018-2023)
Table 27. APAC Psoriatic Arthritis (PsA) Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Region (2018-2023)
Table 29. APAC Psoriatic Arthritis (PsA) Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2018-2023)
Table 31. APAC Psoriatic Arthritis (PsA) Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2018-2023)
Table 33. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Country (2018-2023)
Table 35. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2018-2023)
Table 37. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Psoriatic Arthritis (PsA) Treatment
Table 46. Key Market Challenges & Risks of Psoriatic Arthritis (PsA) Treatment
Table 47. Key Industry Trends of Psoriatic Arthritis (PsA) Treatment
Table 48. Global Psoriatic Arthritis (PsA) Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Psoriatic Arthritis (PsA) Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Psoriatic Arthritis (PsA) Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Pfizer Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 53. Pfizer Psoriatic Arthritis (PsA) Treatment Product Offered
Table 54. Pfizer Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Pfizer Main Business
Table 56. Pfizer Latest Developments
Table 57. Johnson & Johnson Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 58. Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Product Offered
Table 59. Johnson & Johnson Main Business
Table 60. Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Johnson & Johnson Latest Developments
Table 62. AbbVie Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 63. AbbVie Psoriatic Arthritis (PsA) Treatment Product Offered
Table 64. AbbVie Main Business
Table 65. AbbVie Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. AbbVie Latest Developments
Table 67. Novartis Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 68. Novartis Psoriatic Arthritis (PsA) Treatment Product Offered
Table 69. Novartis Main Business
Table 70. Novartis Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Novartis Latest Developments
Table 72. UCB Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 73. UCB Psoriatic Arthritis (PsA) Treatment Product Offered
Table 74. UCB Main Business
Table 75. UCB Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. UCB Latest Developments
Table 77. Roche Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 78. Roche Psoriatic Arthritis (PsA) Treatment Product Offered
Table 79. Roche Main Business
Table 80. Roche Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Roche Latest Developments
Table 82. Bristol-Myers Squibb Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 83. Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Product Offered
Table 84. Bristol-Myers Squibb Main Business
Table 85. Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Bristol-Myers Squibb Latest Developments
Table 87. Eli Lilly Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 88. Eli Lilly Psoriatic Arthritis (PsA) Treatment Product Offered
Table 89. Eli Lilly Main Business
Table 90. Eli Lilly Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Eli Lilly Latest Developments
Table 92. Amgen Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 93. Amgen Psoriatic Arthritis (PsA) Treatment Product Offered
Table 94. Amgen Main Business
Table 95. Amgen Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Amgen Latest Developments
Table 97. AstraZeneca Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 98. AstraZeneca Psoriatic Arthritis (PsA) Treatment Product Offered
Table 99. AstraZeneca Main Business
Table 100. AstraZeneca Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. AstraZeneca Latest Developments
Table 102. Celgene Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 103. Celgene Psoriatic Arthritis (PsA) Treatment Product Offered
Table 104. Celgene Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Celgene Main Business
Table 106. Celgene Latest Developments
LIST OF FIGURES
Figure 1. Psoriatic Arthritis (PsA) Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Psoriatic Arthritis (PsA) Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Psoriatic Arthritis (PsA) Treatment Sales Market Share by Country/Region (2022)
Figure 8. Psoriatic Arthritis (PsA) Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type in 2022
Figure 10. Psoriatic Arthritis (PsA) Treatment in Hospitals
Figure 11. Global Psoriatic Arthritis (PsA) Treatment Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Psoriatic Arthritis (PsA) Treatment in Clinics
Figure 13. Global Psoriatic Arthritis (PsA) Treatment Market: Clinics (2018-2023) & ($ Millions)
Figure 14. Psoriatic Arthritis (PsA) Treatment in Others
Figure 15. Global Psoriatic Arthritis (PsA) Treatment Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application in 2022
Figure 17. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Player in 2022
Figure 18. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Psoriatic Arthritis (PsA) Treatment Market Size 2018-2023 ($ Millions)
Figure 20. APAC Psoriatic Arthritis (PsA) Treatment Market Size 2018-2023 ($ Millions)
Figure 21. Europe Psoriatic Arthritis (PsA) Treatment Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size 2018-2023 ($ Millions)
Figure 23. Americas Psoriatic Arthritis (PsA) Treatment Value Market Share by Country in 2022
Figure 24. United States Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Region in 2022
Figure 29. APAC Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type in 2022
Figure 30. APAC Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application in 2022
Figure 31. China Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Country in 2022
Figure 38. Europe Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2018-2023)
Figure 39. Europe Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2018-2023)
Figure 40. Germany Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 54. APAC Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 55. Europe Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 57. United States Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 58. Canada Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 61. China Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Japan Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 63. Korea Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 65. India Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 66. Australia Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 67. Germany Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 68. France Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 69. UK Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Italy Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Russia Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 72. Spain Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 75. Israel Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 78. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Psoriatic Arthritis (PsA) Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Psoriatic Arthritis (PsA) Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Psoriatic Arthritis (PsA) Treatment Sales Market Share by Country/Region (2022)
Figure 8. Psoriatic Arthritis (PsA) Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type in 2022
Figure 10. Psoriatic Arthritis (PsA) Treatment in Hospitals
Figure 11. Global Psoriatic Arthritis (PsA) Treatment Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Psoriatic Arthritis (PsA) Treatment in Clinics
Figure 13. Global Psoriatic Arthritis (PsA) Treatment Market: Clinics (2018-2023) & ($ Millions)
Figure 14. Psoriatic Arthritis (PsA) Treatment in Others
Figure 15. Global Psoriatic Arthritis (PsA) Treatment Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application in 2022
Figure 17. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Player in 2022
Figure 18. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Psoriatic Arthritis (PsA) Treatment Market Size 2018-2023 ($ Millions)
Figure 20. APAC Psoriatic Arthritis (PsA) Treatment Market Size 2018-2023 ($ Millions)
Figure 21. Europe Psoriatic Arthritis (PsA) Treatment Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size 2018-2023 ($ Millions)
Figure 23. Americas Psoriatic Arthritis (PsA) Treatment Value Market Share by Country in 2022
Figure 24. United States Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Region in 2022
Figure 29. APAC Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type in 2022
Figure 30. APAC Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application in 2022
Figure 31. China Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Country in 2022
Figure 38. Europe Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2018-2023)
Figure 39. Europe Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2018-2023)
Figure 40. Germany Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Psoriatic Arthritis (PsA) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 54. APAC Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 55. Europe Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 57. United States Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 58. Canada Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 61. China Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Japan Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 63. Korea Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 65. India Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 66. Australia Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 67. Germany Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 68. France Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 69. UK Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Italy Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Russia Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 72. Spain Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 75. Israel Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Psoriatic Arthritis (PsA) Treatment Market Size 2024-2029 ($ Millions)
Figure 78. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share Forecast by Application (2024-2029)
